Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7400+0.0900 (+3.40%)
At close: 04:00PM EDT
2.7800 +0.04 (+1.46%)
After hours: 04:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 36.62M
Enterprise value 34.38M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.31
Price/book (mrq)3.16
Enterprise value/revenue 24.87
Enterprise value/EBITDA -0.24

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-36.28%
S&P500 52-week change 323.49%
52-week high 34.8600
52-week low 32.0800
50-day moving average 32.7827
200-day moving average 33.0543

Share statistics

Avg vol (3-month) 362.5k
Avg vol (10-day) 316.67k
Shares outstanding 513.36M
Implied shares outstanding 613.47M
Float 85.74M
% held by insiders 112.80%
% held by institutions 152.73%
Shares short (15 May 2024) 4349.73k
Short ratio (15 May 2024) 49.16
Short % of float (15 May 2024) 42.65%
Short % of shares outstanding (15 May 2024) 42.62%
Shares short (prior month 15 Apr 2024) 4233.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 325 July 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,287.50%

Management effectiveness

Return on assets (ttm)-17.75%
Return on equity (ttm)-132.29%

Income statement

Revenue (ttm)1.38M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)-40.70%
Gross profit (ttm)N/A
EBITDA -20.29M
Net income avi to common (ttm)-40.88M
Diluted EPS (ttm)-5.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.58M
Total cash per share (mrq)0.42
Total debt (mrq)3.33M
Total debt/equity (mrq)19.71%
Current ratio (mrq)0.79
Book value per share (mrq)1.40

Cash flow statement

Operating cash flow (ttm)-18.86M
Levered free cash flow (ttm)-4.68M